Categories: US FDA Approval

Natco Pharma looks for USFDA endorsement for hepatitis medicate

New Delhi, March 03, 2018: Medication firm Natco Pharma today said it has recorded a condensed new medication application (ANDA) for Sofosbuvir Tablets, 400mg, with the United States Food and Drug Administration (USFDA).

Sofosbuvir is utilized for incessant hepatitis C contamination and sold universally by Gilead Sciences, Inc, under its image Sovaldi, Natco Pharma said in a documenting to BSE.

The organization trusts that “they are the first to have documented a generously total ANDA containing a Paragraph IV affirmation for this item and hopes to be qualified for 180 days of advertising restrictiveness after accepting last FDA endorsement,” it included.

For the a year finishing December 31, 2017, Sovaldi had US offers of roughly USD 130 million according to Gilead Sciences Inc’s unaudited comes about discharged for the year finishing December 31, 2017, Natco Pharma said.

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

10 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago